StockNews.com started coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a research report report published on Sunday. The brokerage issued a sell rating on the stock.
SenesTech Stock Up 20.8 %
Shares of SNES stock opened at $2.90 on Friday. The company has a 50 day simple moving average of $3.74 and a two-hundred day simple moving average of $5.83. The company has a quick ratio of 3.49, a current ratio of 4.68 and a debt-to-equity ratio of 0.05. SenesTech has a 12 month low of $1.90 and a 12 month high of $78.00.
SenesTech (NASDAQ:SNES – Get Free Report) last announced its quarterly earnings data on Thursday, August 8th. The company reported ($3.08) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($3.20) by $0.12. The firm had revenue of $0.46 million during the quarter, compared to analysts’ expectations of $0.49 million. SenesTech had a negative net margin of 464.09% and a negative return on equity of 168.64%. During the same period in the prior year, the company posted ($84.03) earnings per share.
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Stories
- Five stocks we like better than SenesTech
- Profitably Trade Stocks at 52-Week Highs
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Buy P&G Now, Before It Sets A New All-Time High
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.
